BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2838975)

  • 1. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
    Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
    West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HBsAg carrier state and primary hepatocellular carcinoma--a ten-year prospective study].
    Lu JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Sep; 22(5):259-62. PubMed ID: 2853039
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma and type B hepatitis.
    Hadziyannis SJ
    Clin Gastroenterol; 1980 Jan; 9(1):117-34. PubMed ID: 6249525
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver disease and hepatitis B infection in a large New Zealand family.
    Milne A; Moyes CD; Pearce NE
    N Z Med J; 1989 Jun; 102(870):318-20. PubMed ID: 2544833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matched prospective study on chronic HBsAg carriers and primary hepatocellular cancer].
    Lu JH
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):406-8. PubMed ID: 6327215
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC; Yuan JM; Ross RK; Govindarajan S
    Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the correlation between primary hepatocellular carcinoma and hepatitis B].
    Lu CQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Feb; 9(1):5-7. PubMed ID: 2838172
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is the disease course in carriers of HBsAg?].
    González A; Guardia J
    Med Clin (Barc); 1989 Dec; 93(19):737-40. PubMed ID: 2560101
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection.
    Seeff LB; Koff RS
    Semin Liver Dis; 1986 Feb; 6(1):11-22. PubMed ID: 3012782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
    Lohiya G; Pirkle H; Hoefs J; Lohiya S; Ngo VT
    Hepatology; 1985; 5(5):824-6. PubMed ID: 2993146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of hepatocellular carcinoma complicating hepatitis B infection in a nine-year-old boy.
    Trounce JQ; Flower AJ; Shannon RS; Tanner MS
    Q J Med; 1985 Nov; 57(223):791-4. PubMed ID: 3001813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.